Mixed Dementia
8
2
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (8)
ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing
Comprehensive Assessment of Neurodegeneration and Dementia
Care of Persons With Dementia in Their Environments (COPE) in Programs of All-Inclusive Care of the Elderly (PACE)
Efficacy Study of Kinto Care Coaching for Dementia Family Caregivers
Telehealth-enabled Integrated Palliative Care for People With Dementia
Feasibility of Passive Data Collection in Dementia Subjects With Agitation
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Mirtazapine in Alzheimer-associated Weight Loss